Arkolith/Insider Trading/TGTX/Form 4

Weiss Michael S

CEO, DirectorTG THERAPEUTICS, INC. (TGTX) · full profile →Form 4 · filed Nov 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 5, 2025Gift(G)3.9M—$010.0M
Nov 5, 2025Gift(G)804K—$09.2M

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-033888) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML